Skip to main content
OpenTrials

Clinical trial condition

Immune System Diseases

Explore clinical trials studying Immune System Diseases. Study availability and eligibility vary by location and protocol.

318 public trials 57 recruiting studies
Refine in advanced search Browse all conditions

Immune System Diseases trial results

Active, Not Recruiting

A Study Evaluating the Efficacy and Safety of Afimetoran Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE)

NCT04895696

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
Locations
  • Local Institution - 0100 Birmingham, Alabama, United States
  • Local Institution - 0123 Huntington Beach, California, United States
  • Local Institution - 0170 La Jolla, California, United States
  • Local Institution - 0159 La Palma, California, United States
View all 147 locations
View Trial Details
Active, Not Recruiting

A Research Study to Evaluate the Effects of a New Oral Medicine Called Cenerimod in Adults With Systemic Lupus Erythematosus

NCT05648500

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +2 more
Locations
  • California Research Institute Huntington Park, California, United States
  • University of Colorado Denver Aurora, Colorado, United States
  • Clinical Research of West Florida, Inc. Clearwater, Florida, United States
  • Omega Research MetroWest, LLC DeBary, Florida, United States
View all 198 locations
View Trial Details
Active, Not Recruiting

A Research Study to Evaluate the Efficacy and Safety of Cenerimod in Subjects Suffering From Systemic Lupus Erythematosus

NCT05672576

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +2 more
Locations
  • Tucson Clinical Research Institute, LLC Tucson, Arizona, United States
  • UCSD Perlman Medical Offices La Jolla, California, United States
  • Amicis Research Center Northridge, California, United States
  • Hope Clinical Trials, Inc. Coral Gables, Florida, United States
View all 147 locations
View Trial Details
Active, Not Recruiting

Determine Effectiveness of Anifrolumab In SYstemic Sclerosis (DAISY)

NCT05925803

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +9 more
Locations
  • Research Site Scottsdale, Arizona, United States
  • Research Site Chula Vista, California, United States
  • Research Site Los Angeles, California, United States
  • Research Site Orange, California, United States
View all 150 locations
View Trial Details
Active, Not Recruiting

Phase 2 Placebo-Controlled Study to Assess the Safety and Efficacy of ESK-001 in Active Systemic Lupus Erythematosus

NCT05966480

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
Locations
  • Investigator Site #1046 Anniston, Alabama, United States
  • Investigator Site #1104 La Jolla, California, United States
  • Investigator Site #1050 Los Alamitos, California, United States
  • Investigator Site #1168 Mission Hills, California, United States
View all 169 locations
View Trial Details
Active, Not Recruiting

Tibulizumab Systemic Sclerosis Understanding and Response Evaluation (TibuSURE)

NCT06843239

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +9 more
Locations
  • UCSD Altman Clinical and Translational Research Institute Center for Clinical Research La Jolla, California, United States
  • UCLA Department of Medicine Los Angeles, California, United States
  • IRIS Research and Development LLC Plantation, Florida, United States
  • University of Iowa Iowa City, Iowa, United States
View all 60 locations
View Trial Details

Related conditions